Nuvectra (NVTR) Trading 1.1% Higher

Nuvectra Corp (NASDAQ:NVTR)’s share price traded up 1.1% during trading on Friday . The company traded as high as $9.11 and last traded at $8.93. 53,115 shares changed hands during mid-day trading, a decline of 57% from the average session volume of 122,874 shares. The stock had previously closed at $8.83.

A number of equities analysts have commented on the company. ValuEngine raised Nuvectra from a “strong sell” rating to a “sell” rating in a research note on Wednesday. Piper Jaffray Companies reissued a “hold” rating and issued a $12.00 price objective on shares of Nuvectra in a research note on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. Nuvectra currently has a consensus rating of “Hold” and an average target price of $12.00.

The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.72 and a current ratio of 2.90. The stock has a market cap of $95.80, a P/E ratio of -1.90 and a beta of -0.51.

Nuvectra (NASDAQ:NVTR) last issued its quarterly earnings results on Wednesday, November 1st. The company reported ($1.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.16) by $0.07. Nuvectra had a negative return on equity of 68.63% and a negative net margin of 204.19%. The business had revenue of $7.60 million for the quarter, compared to analyst estimates of $8.08 million. During the same quarter in the prior year, the firm posted ($0.92) earnings per share. The firm’s revenue for the quarter was up 100.0% compared to the same quarter last year. analysts expect that Nuvectra Corp will post -4.58 EPS for the current year.

Several institutional investors and hedge funds have recently modified their holdings of NVTR. OxFORD Asset Management LLP acquired a new position in shares of Nuvectra during the second quarter valued at $154,000. FNY Partners Fund LP lifted its stake in shares of Nuvectra by 449.6% during the third quarter. FNY Partners Fund LP now owns 13,740 shares of the company’s stock valued at $182,000 after acquiring an additional 11,240 shares during the period. Stifel Financial Corp lifted its stake in shares of Nuvectra by 6.2% during the second quarter. Stifel Financial Corp now owns 34,227 shares of the company’s stock valued at $444,000 after acquiring an additional 1,999 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Nuvectra by 1.3% during the second quarter. Wells Fargo & Company MN now owns 114,492 shares of the company’s stock valued at $1,520,000 after acquiring an additional 1,495 shares during the period. Finally, Northern Trust Corp lifted its stake in shares of Nuvectra by 1.7% during the second quarter. Northern Trust Corp now owns 169,659 shares of the company’s stock valued at $2,253,000 after acquiring an additional 2,811 shares during the period. 58.84% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://sportsperspectives.com/2018/02/04/nuvectra-nvtr-trading-1-1-higher.html.

About Nuvectra

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply